Page last updated: 2024-08-23

nimustine and Complication, Postoperative

nimustine has been researched along with Complication, Postoperative in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, XL; Li, HL; Lin, S; Zhang, JN	1
Kajita, Y; Sugita, K; Wakabayashi, T; Yoshida, J	1
Fukamachi, A; Kimurat, R; Naganuma, H; Nukui, H; Sasaki, A; Tasaka, K	1

Trials

2 trial(s) available for nimustine and Complication, Postoperative

Article	Year
Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor. Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:7 Topics: Adult; Aged; Brain Edema; Brain Neoplasms; Cisplatin; Dacarbazine; Down-Regulation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Nimustine; Postoperative Complications; Temozolomide; Thrombocytopenia; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult	2014
Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation. Acta neurochirurgica, 1994, Volume: 127, Issue:1-2 Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Female; Follow-Up Studies; Glioblastoma; Humans; Infant; Interferon-beta; Male; Middle Aged; Nimustine; Postoperative Complications; Radiotherapy, Adjuvant; Survival Rate	1994

Article

Year

Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor.

Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:7

Topics: Adult; Aged; Brain Edema; Brain Neoplasms; Cisplatin; Dacarbazine; Down-Regulation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Nimustine; Postoperative Complications; Temozolomide; Thrombocytopenia; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult

2014

Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation.

Acta neurochirurgica, 1994, Volume: 127, Issue:1-2

Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Female; Follow-Up Studies; Glioblastoma; Humans; Infant; Interferon-beta; Male; Middle Aged; Nimustine; Postoperative Complications; Radiotherapy, Adjuvant; Survival Rate

1994

Other Studies

1 other study(ies) available for nimustine and Complication, Postoperative

Article	Year
Complete remission of recurrent glioblastoma multiforme following local infusions of lymphokine activated killer cells. Case report. Acta neurochirurgica, 1989, Volume: 99, Issue:3-4 Topics: Adult; Brain Neoplasms; Combined Modality Therapy; Frontal Lobe; Glioblastoma; Humans; Immunization, Passive; Interferon Type I; Interleukin-2; Killer Cells, Natural; Male; Neoplasm Recurrence, Local; Nimustine; Parietal Lobe; Postoperative Complications; Recombinant Proteins	1989

Article

Year

Complete remission of recurrent glioblastoma multiforme following local infusions of lymphokine activated killer cells. Case report.

Acta neurochirurgica, 1989, Volume: 99, Issue:3-4

Topics: Adult; Brain Neoplasms; Combined Modality Therapy; Frontal Lobe; Glioblastoma; Humans; Immunization, Passive; Interferon Type I; Interleukin-2; Killer Cells, Natural; Male; Neoplasm Recurrence, Local; Nimustine; Parietal Lobe; Postoperative Complications; Recombinant Proteins

1989